GREENWOOD VILLAGE, Colo., Sept. 17, 2019 /PRNewswire/ -- Safe Rx and Vail Health today announced the launch of a Locking Pill Bottle dispensing program in Vail Health's outpatient pharmacies in Vail and Edwards. Patients will now be offered Safe Rx's Locking Pill Bottles (LPBs®) for all controlled

NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of MacroGenics, Inc. ("MacroGenics" or the "Company") (NASDAQ: MGNX) between February 6, 2019 and

WASHINGTON, Sept. 17, 2019 /PRNewswire/ -- Fertility in the United States dropped to the lowest level in recorded history, with women having an average of 1.7 births in their lifetime. This is according to the

SANTA ROSA, Calif., Sept. 17, 2019 /PRNewswire/ -- Imagine having the independence and peace of mind to venture out into public for the very first time, thanks to a task-trained service dog. Every day, people with disabilities from paralysis to post-traumatic stress, are living fuller and more independent lives thanks to their service dog. That newfound independence

CROMWELL, Conn., Sept. 17, 2019 /PRNewswire/ -- Culturelle®, the #1 probiotic in the world††† has partnered with actress, entrepreneur and mom, Jessica Alba for a multi-year collaboration. The project will launch with a new omnichannel advertising cam

GENEVA, Sept. 17, 2019 /PRNewswire/ -- FDI World Dental Federation (FDI) welcomes the long overdue commitment to strengthening oral health in the UN Political Declaration on Universal Health Coverage (UHC). The declaration will be offic

MILFORD, Mich., Sept. 17, 2019 /PRNewswire/ -- A Michigan federal judge has barred BlephEx LLC from making allegations of patent infringement and threatening litigation against customers of Myco Industries, Inc. regarding Myco's AB Max™.

NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that the Company has executed an exclusive option agreement ("Option") with the University of Maryland, Baltimore (UMB) related to its anticancer drug designated PrAg-PAS, a novel protein drug designed by re-engineering the anthrax toxin delivery

LEAWOOD, Kan., Sept. 17, 2019 /PRNewswire/ -- MUVE Health, A ValueHealth company, a leader in total joint replacement surgery, announces the creation of a new Advisory Board.  This advisory board is comprised of a strategic committee of executive-level surgeons serving as trusted advisors to MUVE Health on strategy and innovation as we begin to navigate through

NEW YORK, Sept. 17, 2019 /PRNewswire/ -- A recent study of active professional NFL players by Weill Cornell Medicine published in the Journal of Neurosurgery on September 6, 2019, found that comparing concussed players' advanced quantitative diffusion MRI scans with their baseline MRI scans using advanced image analysis may be a key metric f